Targeting the lactate transporter monocarboxylate transporter 1 constitutes a new therapeutic modality that disrupts a fundamental metabolic symbiosis in tumors
(2010) 21st meeting of the European Association for Cancer Research (EACR21), Presidential Session — Location: Oslo, Norway (26.June.2010)
